Abstract
Vascular anomalies frequently involve the face and lateral face, making them difficult to treat, as all treatments can cause facial disfigurement and motor nerve dysfunction. This chapter highlights the unique treatment challenges these lesions pose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
**Achache M, Fakhry N, Varoquaux A, et al. Management of vascular malformations of the parotid area. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(2):55–60.
Sinno H, Thibaudeau S, Coughlin R, Chitte S, Williams B. Management of infantile parotid gland hemangiomas: a 40-year experience. Plast Reconstr Surg. 2010;125(1):265–73.
Youssef JS, Quraishi HA. Cervicofacial hemangioma and its association with PHACE syndrome. Otolaryngol Head Neck Surg. 2003;128(5):758–60.
Rudnick EF, Chen EY, Manning SC, Perkins JA. PHACES syndrome: otolaryngic considerations in recognition and management. Int J Pediatr Otorhinolaryngol. 2009;73(2):281–8.
Richter GT, Braswell L. Management of venous malformations. Facial Plast Surg. 2012;28(6):603–10.
Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(4):1048–54.e1–5. Accessed 20150330; 12/17/2015 5:54:01 PM. https://doi.org/10.1016/j.jpeds.2014.12.069.
Maclellan RA, Luks VL, Vivero MP, et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg. 2014;133(1):12e–9e.
Soblet J, Kangas J, Natynki M, et al. Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol. 2017;137(1):207–16.
Natynki M, Kangas J, Miinalainen I, et al. Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet. 2015;24(22):6374–89.
***de Serres LM, Sie KC, Richardson MA. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg. 1995;121(5):577–82.
Li G, Xu D, Tong S, Xue L, Sun N, Wang X. Oral propranolol with topical timolol maleate therapy for mixed infantile hemangiomas in oral and maxillofacial regions. J Craniofac Surg. 2016;27(1):56–60. Accessed 20160109; 8/29/2016 4:53:56 PM. https://doi.org/10.1097/SCS.0000000000002221.
Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope. 2001;111(11 Pt 1):1929–37.
Wiegand S, Eivazi B, Zimmermann AP, Sesterhenn AM, Werner JA. Sclerotherapy of lymphangiomas of the head and neck. Head Neck. 2011;33(11):1649–55.
Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg. 2014;140(1):41–5.
Strychowsky JE, Rahbar R, O’Hare MJ, Irace AL, Padua H. Trenor CC,3rd. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope. 2018;128(1):269–76.
Smith MC, Zimmerman MB, Burke DK, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009;119(1):107–15. Accessed 20090122. https://doi.org/10.1002/lary.20041.
Chiara J, Kinney G, Slimp J, Lee GS, Oliaei S, Perkins JA. Facial nerve mapping and monitoring in lymphatic malformation surgery. Int J Pediatr Otorhinolaryngol. 2009;73(10):1348–52.
Lee GS, Perkins JA, Oliaei S, Manning SC. Facial nerve anatomy, dissection and preservation in lymphatic malformation management. Int J Pediatr Otorhinolaryngol. 2008;72(6):759–66.
Demiri EC, Pelissier P, Genin-Etcheberry T, Tsakoniatis N, Martin D, Baudet J. Treatment of facial haemangiomas: the present status of surgery. Br J Plast Surg. 2001;54(8):665–74.
Li G, Xu DP, Sun HL, et al. Oral propranolol for parotid infantile hemangiomas. J Craniofac Surg. 2015;26(2):438–40.
Ulkatan S, Waner M, Arranz-Arranz B, et al. New methodology for facial nerve monitoring in extracranial surgeries of vascular malformations. Clin Neurophysiol. 2014;125(4):849–55.
**Bly RA, Holdefer RN, Slimp J, et al. Preoperative facial nerve mapping to plan and guide pediatric facial vascular anomaly resection. JAMA Otolaryngol Head Neck Surg. 2018;144:418–26.
To assist the reader in gaining familiarity with available evidence, the following rating system has been used to indicate key references for each chapter’s content:
***: Critical material. Anyone dealing with this condition should be familiar with this reference.
**: Useful material. Important information that is valuable in in clinical or scientific practice related to this condition.
*: Optional material. For readers with a strong interest in the chapter content or a desire to study it in greater depth.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Miller, C., Bly, R.A. (2018). Parotid and Deep Vascular Tumors. In: Perkins, J., Balakrishnan, K. (eds) Evidence-Based Management of Head and Neck Vascular Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-319-92306-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-92306-2_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92305-5
Online ISBN: 978-3-319-92306-2
eBook Packages: MedicineMedicine (R0)